190 filings
Page 5 of 10
8-K
3jfjox8 dtbrrew
28 Mar 19
Entry into a Material Definitive Agreement
8:45am
8-K
s0cz64 1532da
12 Mar 19
NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy
4:30pm
8-K
osn lbtfk27iw
11 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
j5a2r7vy8lpg
1 Mar 19
Entry into a Material Definitive Agreement
12:00am
8-K
mmobby3j uq5bc807n
11 Oct 18
Departure of Directors or Certain Officers
4:30pm
8-K
2bpbem9
28 Sep 18
NovaBay Pharmaceuticals Names Jack McGovern Interim CEO
4:30pm
8-K
yf7btt88msh 4t7cbque
4 Jun 18
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
0fca41s4ky
26 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
h3diy
23 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
uwobgv05zapp nbxx
12 Feb 18
NovaBay Pharmaceuticals Completes $6.0 Million Private Placement
12:00am
8-K
y4176er jk7a4
6 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
3bvfm0
6 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
6cpi4n0ef jm0i
22 Dec 17
NovaBay Pharmaceuticals Receives Stockholder Approval for Proposed $10.32 Million Financing Agreement
12:00am
8-K
czmm55e
20 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
ft3i0nxxajlc2
12 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
rr17 r4qk
28 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
ri8knslhjb
21 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
93rl0zvie du5yw3qn
20 Sep 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
ybyq 0ydkj4
10 Jul 17
NovaBayPharmaceuticals Announces CFO Transition
12:00am
8-K
yrvwb
6 Jun 17
Departure of Directors or Certain Officers
12:00am